English
简体中文
Total: £ 56.28
Published Date: 2025-11-05 | Pages: 167 | Tables: 161 | Pharma & Healthcare
The global Solid Oral Nutraceutical Excipient market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
From a downstream perspective, Protein Supplements accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Solid Oral Nutraceutical Excipient leading manufacturers including Kerry Group, Cargill, BASF, Ingredion, Roquette Freres, JRS Pharma, Evonik, Ashland, Colorcon, BENEO, etc., dominate supply; the top five capture approximately % of global revenue, with Kerry Group leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Solid Oral Nutraceutical Excipient market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Kerry Group
Cargill
BASF
Ingredion
Roquette Freres
JRS Pharma
Evonik
Ashland
Colorcon
BENEO
Azelis
SEPPIC
Biogrund
Sigachi Industries
Segment by Type
Natural
Synthetic
Segment by Application
Protein Supplements
Probiotic Supplements
Vitamin Supplements
Mineral Supplements
Others
Sales by Region
North America
U.S.
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia (Indonesia, Vietnam, Thailand)
India
Europe
Germany
France
U.K.
Italy
Russia
Central South America
Brazil
Argentina
Middle East, Africa
Turkey
Egypt
GCC Countries
South Africa
Chapter Outline
Chapter 1: Defines the Solid Oral Nutraceutical Excipient study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Study Coverage
1.1 Introduction to Solid Oral Nutraceutical Excipient: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Solid Oral Nutraceutical Excipient Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Natural
1.2.3 Synthetic
1.3 Market Segmentation by Application
1.3.1 Global Solid Oral Nutraceutical Excipient Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Protein Supplements
1.3.3 Probiotic Supplements
1.3.4 Vitamin Supplements
1.3.5 Mineral Supplements
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Solid Oral Nutraceutical Excipient Revenue Estimates and Forecasts 2020-2031
2.2 Global Solid Oral Nutraceutical Excipient Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Solid Oral Nutraceutical Excipient Sales Estimates and Forecasts 2020-2031
2.4 Global Solid Oral Nutraceutical Excipient Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Solid Oral Nutraceutical Excipient Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Solid Oral Nutraceutical Excipient Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Natural Market Size by Manufacturers
3.5.2 Synthetic Market Size by Manufacturers
3.6 Global Solid Oral Nutraceutical Excipient Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Solid Oral Nutraceutical Excipient Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Solid Oral Nutraceutical Excipient Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Solid Oral Nutraceutical Excipient Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Solid Oral Nutraceutical Excipient Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Solid Oral Nutraceutical Excipient Sales and Revenue by Type (2020-2031)
6.4 North America Solid Oral Nutraceutical Excipient Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Solid Oral Nutraceutical Excipient Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Solid Oral Nutraceutical Excipient Sales and Revenue by Type (2020-2031)
7.4 Europe Solid Oral Nutraceutical Excipient Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Solid Oral Nutraceutical Excipient Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Solid Oral Nutraceutical Excipient Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Solid Oral Nutraceutical Excipient Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Solid Oral Nutraceutical Excipient Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Solid Oral Nutraceutical Excipient Sales and Revenue by Type (2020-2031)
9.4 Central and South America Solid Oral Nutraceutical Excipient Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Solid Oral Nutraceutical Excipient Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Solid Oral Nutraceutical Excipient Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Solid Oral Nutraceutical Excipient Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Solid Oral Nutraceutical Excipient Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Kerry Group
11.1.1 Kerry Group Corporation Information
11.1.2 Kerry Group Business Overview
11.1.3 Kerry Group Solid Oral Nutraceutical Excipient Product Models, Descriptions and Specifications
11.1.4 Kerry Group Solid Oral Nutraceutical Excipient Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Kerry Group Solid Oral Nutraceutical Excipient Sales by Product in 2024
11.1.6 Kerry Group Solid Oral Nutraceutical Excipient Sales by Application in 2024
11.1.7 Kerry Group Solid Oral Nutraceutical Excipient Sales by Geographic Area in 2024
11.1.8 Kerry Group Solid Oral Nutraceutical Excipient SWOT Analysis
11.1.9 Kerry Group Recent Developments
11.2 Cargill
11.2.1 Cargill Corporation Information
11.2.2 Cargill Business Overview
11.2.3 Cargill Solid Oral Nutraceutical Excipient Product Models, Descriptions and Specifications
11.2.4 Cargill Solid Oral Nutraceutical Excipient Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Cargill Solid Oral Nutraceutical Excipient Sales by Product in 2024
11.2.6 Cargill Solid Oral Nutraceutical Excipient Sales by Application in 2024
11.2.7 Cargill Solid Oral Nutraceutical Excipient Sales by Geographic Area in 2024
11.2.8 Cargill Solid Oral Nutraceutical Excipient SWOT Analysis
11.2.9 Cargill Recent Developments
11.3 BASF
11.3.1 BASF Corporation Information
11.3.2 BASF Business Overview
11.3.3 BASF Solid Oral Nutraceutical Excipient Product Models, Descriptions and Specifications
11.3.4 BASF Solid Oral Nutraceutical Excipient Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 BASF Solid Oral Nutraceutical Excipient Sales by Product in 2024
11.3.6 BASF Solid Oral Nutraceutical Excipient Sales by Application in 2024
11.3.7 BASF Solid Oral Nutraceutical Excipient Sales by Geographic Area in 2024
11.3.8 BASF Solid Oral Nutraceutical Excipient SWOT Analysis
11.3.9 BASF Recent Developments
11.4 Ingredion
11.4.1 Ingredion Corporation Information
11.4.2 Ingredion Business Overview
11.4.3 Ingredion Solid Oral Nutraceutical Excipient Product Models, Descriptions and Specifications
11.4.4 Ingredion Solid Oral Nutraceutical Excipient Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Ingredion Solid Oral Nutraceutical Excipient Sales by Product in 2024
11.4.6 Ingredion Solid Oral Nutraceutical Excipient Sales by Application in 2024
11.4.7 Ingredion Solid Oral Nutraceutical Excipient Sales by Geographic Area in 2024
11.4.8 Ingredion Solid Oral Nutraceutical Excipient SWOT Analysis
11.4.9 Ingredion Recent Developments
11.5 Roquette Freres
11.5.1 Roquette Freres Corporation Information
11.5.2 Roquette Freres Business Overview
11.5.3 Roquette Freres Solid Oral Nutraceutical Excipient Product Models, Descriptions and Specifications
11.5.4 Roquette Freres Solid Oral Nutraceutical Excipient Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Roquette Freres Solid Oral Nutraceutical Excipient Sales by Product in 2024
11.5.6 Roquette Freres Solid Oral Nutraceutical Excipient Sales by Application in 2024
11.5.7 Roquette Freres Solid Oral Nutraceutical Excipient Sales by Geographic Area in 2024
11.5.8 Roquette Freres Solid Oral Nutraceutical Excipient SWOT Analysis
11.5.9 Roquette Freres Recent Developments
11.6 JRS Pharma
11.6.1 JRS Pharma Corporation Information
11.6.2 JRS Pharma Business Overview
11.6.3 JRS Pharma Solid Oral Nutraceutical Excipient Product Models, Descriptions and Specifications
11.6.4 JRS Pharma Solid Oral Nutraceutical Excipient Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 JRS Pharma Recent Developments
11.7 Evonik
11.7.1 Evonik Corporation Information
11.7.2 Evonik Business Overview
11.7.3 Evonik Solid Oral Nutraceutical Excipient Product Models, Descriptions and Specifications
11.7.4 Evonik Solid Oral Nutraceutical Excipient Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Evonik Recent Developments
11.8 Ashland
11.8.1 Ashland Corporation Information
11.8.2 Ashland Business Overview
11.8.3 Ashland Solid Oral Nutraceutical Excipient Product Models, Descriptions and Specifications
11.8.4 Ashland Solid Oral Nutraceutical Excipient Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Ashland Recent Developments
11.9 Colorcon
11.9.1 Colorcon Corporation Information
11.9.2 Colorcon Business Overview
11.9.3 Colorcon Solid Oral Nutraceutical Excipient Product Models, Descriptions and Specifications
11.9.4 Colorcon Solid Oral Nutraceutical Excipient Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Colorcon Recent Developments
11.10 BENEO
11.10.1 BENEO Corporation Information
11.10.2 BENEO Business Overview
11.10.3 BENEO Solid Oral Nutraceutical Excipient Product Models, Descriptions and Specifications
11.10.4 BENEO Solid Oral Nutraceutical Excipient Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 BENEO Recent Developments
11.11 Azelis
11.11.1 Azelis Corporation Information
11.11.2 Azelis Business Overview
11.11.3 Azelis Solid Oral Nutraceutical Excipient Product Models, Descriptions and Specifications
11.11.4 Azelis Solid Oral Nutraceutical Excipient Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 Azelis Recent Developments
11.12 SEPPIC
11.12.1 SEPPIC Corporation Information
11.12.2 SEPPIC Business Overview
11.12.3 SEPPIC Solid Oral Nutraceutical Excipient Product Models, Descriptions and Specifications
11.12.4 SEPPIC Solid Oral Nutraceutical Excipient Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 SEPPIC Recent Developments
11.13 Biogrund
11.13.1 Biogrund Corporation Information
11.13.2 Biogrund Business Overview
11.13.3 Biogrund Solid Oral Nutraceutical Excipient Product Models, Descriptions and Specifications
11.13.4 Biogrund Solid Oral Nutraceutical Excipient Sales, Price, Revenue and Gross Margin (2020-2025)
11.13.5 Biogrund Recent Developments
11.14 Sigachi Industries
11.14.1 Sigachi Industries Corporation Information
11.14.2 Sigachi Industries Business Overview
11.14.3 Sigachi Industries Solid Oral Nutraceutical Excipient Product Models, Descriptions and Specifications
11.14.4 Sigachi Industries Solid Oral Nutraceutical Excipient Sales, Price, Revenue and Gross Margin (2020-2025)
11.14.5 Sigachi Industries Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Solid Oral Nutraceutical Excipient Industry Chain
12.2 Solid Oral Nutraceutical Excipient Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Solid Oral Nutraceutical Excipient Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Solid Oral Nutraceutical Excipient Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Solid Oral Nutraceutical Excipient Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Solid Oral Nutraceutical Excipient Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
Table 1. Global Solid Oral Nutraceutical Excipient Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Solid Oral Nutraceutical Excipient Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Solid Oral Nutraceutical Excipient Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Solid Oral Nutraceutical Excipient Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Solid Oral Nutraceutical Excipient Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Solid Oral Nutraceutical Excipient Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global Solid Oral Nutraceutical Excipient Sales by Region (2020-2025) & (K Units)
Table 8. Global Solid Oral Nutraceutical Excipient Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Solid Oral Nutraceutical Excipient Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global Solid Oral Nutraceutical Excipient Sales Share by Manufacturers (2020-2025)
Table 12. Global Solid Oral Nutraceutical Excipient Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Solid Oral Nutraceutical Excipient Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Solid Oral Nutraceutical Excipient by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Solid Oral Nutraceutical Excipient as of 2024)
Table 16. Global Solid Oral Nutraceutical Excipient Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Solid Oral Nutraceutical Excipient Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers Solid Oral Nutraceutical Excipient Manufacturing Base and Headquarters
Table 19. Global Solid Oral Nutraceutical Excipient Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Solid Oral Nutraceutical Excipient Sales by Type (2020-2025) & (K Units)
Table 23. Global Solid Oral Nutraceutical Excipient Sales by Type (2026-2031) & (K Units)
Table 24. Global Solid Oral Nutraceutical Excipient Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Solid Oral Nutraceutical Excipient Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Solid Oral Nutraceutical Excipient ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Solid Oral Nutraceutical Excipient Sales by Application (2020-2025) & (K Units)
Table 29. Global Solid Oral Nutraceutical Excipient Sales by Application (2026-2031) & (K Units)
Table 30. Solid Oral Nutraceutical Excipient High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Solid Oral Nutraceutical Excipient Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Solid Oral Nutraceutical Excipient Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Solid Oral Nutraceutical Excipient ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Solid Oral Nutraceutical Excipient Growth Accelerators and Market Barriers
Table 37. North America Solid Oral Nutraceutical Excipient Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Solid Oral Nutraceutical Excipient Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Solid Oral Nutraceutical Excipient Growth Accelerators and Market Barriers
Table 40. Europe Solid Oral Nutraceutical Excipient Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Solid Oral Nutraceutical Excipient Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Solid Oral Nutraceutical Excipient Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Solid Oral Nutraceutical Excipient Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Solid Oral Nutraceutical Excipient Growth Accelerators and Market Barriers
Table 45. Southeast Asia Solid Oral Nutraceutical Excipient Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Solid Oral Nutraceutical Excipient Investment Opportunities and Key Challenges
Table 47. Central and South America Solid Oral Nutraceutical Excipient Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Solid Oral Nutraceutical Excipient Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Solid Oral Nutraceutical Excipient Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Kerry Group Corporation Information
Table 51. Kerry Group Description and Major Businesses
Table 52. Kerry Group Product Models, Descriptions and Specifications
Table 53. Kerry Group Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. Kerry Group Sales Value Proportion by Product in 2024
Table 55. Kerry Group Sales Value Proportion by Application in 2024
Table 56. Kerry Group Sales Value Proportion by Geographic Area in 2024
Table 57. Kerry Group Solid Oral Nutraceutical Excipient SWOT Analysis
Table 58. Kerry Group Recent Developments
Table 59. Cargill Corporation Information
Table 60. Cargill Description and Major Businesses
Table 61. Cargill Product Models, Descriptions and Specifications
Table 62. Cargill Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. Cargill Sales Value Proportion by Product in 2024
Table 64. Cargill Sales Value Proportion by Application in 2024
Table 65. Cargill Sales Value Proportion by Geographic Area in 2024
Table 66. Cargill Solid Oral Nutraceutical Excipient SWOT Analysis
Table 67. Cargill Recent Developments
Table 68. BASF Corporation Information
Table 69. BASF Description and Major Businesses
Table 70. BASF Product Models, Descriptions and Specifications
Table 71. BASF Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. BASF Sales Value Proportion by Product in 2024
Table 73. BASF Sales Value Proportion by Application in 2024
Table 74. BASF Sales Value Proportion by Geographic Area in 2024
Table 75. BASF Solid Oral Nutraceutical Excipient SWOT Analysis
Table 76. BASF Recent Developments
Table 77. Ingredion Corporation Information
Table 78. Ingredion Description and Major Businesses
Table 79. Ingredion Product Models, Descriptions and Specifications
Table 80. Ingredion Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Ingredion Sales Value Proportion by Product in 2024
Table 82. Ingredion Sales Value Proportion by Application in 2024
Table 83. Ingredion Sales Value Proportion by Geographic Area in 2024
Table 84. Ingredion Solid Oral Nutraceutical Excipient SWOT Analysis
Table 85. Ingredion Recent Developments
Table 86. Roquette Freres Corporation Information
Table 87. Roquette Freres Description and Major Businesses
Table 88. Roquette Freres Product Models, Descriptions and Specifications
Table 89. Roquette Freres Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Roquette Freres Sales Value Proportion by Product in 2024
Table 91. Roquette Freres Sales Value Proportion by Application in 2024
Table 92. Roquette Freres Sales Value Proportion by Geographic Area in 2024
Table 93. Roquette Freres Solid Oral Nutraceutical Excipient SWOT Analysis
Table 94. Roquette Freres Recent Developments
Table 95. JRS Pharma Corporation Information
Table 96. JRS Pharma Description and Major Businesses
Table 97. JRS Pharma Product Models, Descriptions and Specifications
Table 98. JRS Pharma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. JRS Pharma Recent Developments
Table 100. Evonik Corporation Information
Table 101. Evonik Description and Major Businesses
Table 102. Evonik Product Models, Descriptions and Specifications
Table 103. Evonik Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. Evonik Recent Developments
Table 105. Ashland Corporation Information
Table 106. Ashland Description and Major Businesses
Table 107. Ashland Product Models, Descriptions and Specifications
Table 108. Ashland Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. Ashland Recent Developments
Table 110. Colorcon Corporation Information
Table 111. Colorcon Description and Major Businesses
Table 112. Colorcon Product Models, Descriptions and Specifications
Table 113. Colorcon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 114. Colorcon Recent Developments
Table 115. BENEO Corporation Information
Table 116. BENEO Description and Major Businesses
Table 117. BENEO Product Models, Descriptions and Specifications
Table 118. BENEO Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 119. BENEO Recent Developments
Table 120. Azelis Corporation Information
Table 121. Azelis Description and Major Businesses
Table 122. Azelis Product Models, Descriptions and Specifications
Table 123. Azelis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 124. Azelis Recent Developments
Table 125. SEPPIC Corporation Information
Table 126. SEPPIC Description and Major Businesses
Table 127. SEPPIC Product Models, Descriptions and Specifications
Table 128. SEPPIC Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 129. SEPPIC Recent Developments
Table 130. Biogrund Corporation Information
Table 131. Biogrund Description and Major Businesses
Table 132. Biogrund Product Models, Descriptions and Specifications
Table 133. Biogrund Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 134. Biogrund Recent Developments
Table 135. Sigachi Industries Corporation Information
Table 136. Sigachi Industries Description and Major Businesses
Table 137. Sigachi Industries Product Models, Descriptions and Specifications
Table 138. Sigachi Industries Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 139. Sigachi Industries Recent Developments
Table 140. Key Raw Materials Distribution
Table 141. Raw Materials Key Suppliers
Table 142. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 143. Milestones in Production Technology Evolution
Table 144. Distributors List
Table 145. Market Trends and Market Evolution
Table 146. Market Drivers and Opportunities
Table 147. Market Challenges, Risks, and Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Solid Oral Nutraceutical Excipient Product Picture
Figure 2. Global Solid Oral Nutraceutical Excipient Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Natural Product Picture
Figure 4. Synthetic Product Picture
Figure 5. Global Solid Oral Nutraceutical Excipient Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Protein Supplements
Figure 7. Probiotic Supplements
Figure 8. Vitamin Supplements
Figure 9. Mineral Supplements
Figure 10. Others
Figure 11. Solid Oral Nutraceutical Excipient Report Years Considered
Figure 12. Global Solid Oral Nutraceutical Excipient Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Solid Oral Nutraceutical Excipient Revenue (2020-2031) & (US$ Million)
Figure 14. Global Solid Oral Nutraceutical Excipient Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 15. Global Solid Oral Nutraceutical Excipient Revenue Market Share by Region (2020-2031)
Figure 16. Global Solid Oral Nutraceutical Excipient Sales (2020-2031) & (K Units)
Figure 17. Global Solid Oral Nutraceutical Excipient Sales (CAGR) by Region (2020-2031) (K Units)
Figure 18. Global Solid Oral Nutraceutical Excipient Sales Market Share by Region (2020-2031)
Figure 19. Top 5 and Top 10 Manufacturers Solid Oral Nutraceutical Excipient Sales Volume Market Share in 2024
Figure 20. Global Solid Oral Nutraceutical Excipient Revenue Market Share Ranking (2024)
Figure 21. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 22. Natural Revenue Market Share by Manufacturer in 2024
Figure 23. Synthetic Revenue Market Share by Manufacturer in 2024
Figure 24. Global Solid Oral Nutraceutical Excipient Sales Market Share by Type (2020-2031)
Figure 25. Global Solid Oral Nutraceutical Excipient Revenue Market Share by Type (2020-2031)
Figure 26. Global Solid Oral Nutraceutical Excipient Sales Market Share by Application (2020-2031)
Figure 27. Global Solid Oral Nutraceutical Excipient Revenue Market Share by Application (2020-2031)
Figure 28. North America Solid Oral Nutraceutical Excipient Sales YoY (2020-2031) & (K Units)
Figure 29. North America Solid Oral Nutraceutical Excipient Revenue YoY (2020-2031) & (US$ Million)
Figure 30. North America Top 5 Manufacturers Solid Oral Nutraceutical Excipient Sales Revenue (US$ Million) in 2024
Figure 31. North America Solid Oral Nutraceutical Excipient Sales Volume (K Units) by Type (2020- 2031)
Figure 32. North America Solid Oral Nutraceutical Excipient Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 33. North America Solid Oral Nutraceutical Excipient Sales Volume (K Units) by Application (2020-2031)
Figure 34. North America Solid Oral Nutraceutical Excipient Sales Revenue (US$ Million) by Application (2020-2031)
Figure 35. US Solid Oral Nutraceutical Excipient Revenue (2020-2031) & (US$ Million)
Figure 36. Canada Solid Oral Nutraceutical Excipient Revenue (2020-2031) & (US$ Million)
Figure 37. Mexico Solid Oral Nutraceutical Excipient Revenue (2020-2031) & (US$ Million)
Figure 38. Europe Solid Oral Nutraceutical Excipient Sales YoY (2020-2031) & (K Units)
Figure 39. Europe Solid Oral Nutraceutical Excipient Revenue YoY (2020-2031) & (US$ Million)
Figure 40. Europe Top 5 Manufacturers Solid Oral Nutraceutical Excipient Sales Revenue (US$ Million) in 2024
Figure 41. Europe Solid Oral Nutraceutical Excipient Sales Volume (K Units) by Type (2020-2031)
Figure 42. Europe Solid Oral Nutraceutical Excipient Sales Revenue (US$ Million) by Type (2020-2031)
Figure 43. Europe Solid Oral Nutraceutical Excipient Sales Volume (K Units) by Application (2020-2031)
Figure 44. Europe Solid Oral Nutraceutical Excipient Sales Revenue (US$ Million) by Application (2020-2031)
Figure 45. Germany Solid Oral Nutraceutical Excipient Revenue (2020-2031) & (US$ Million)
Figure 46. France Solid Oral Nutraceutical Excipient Revenue (2020-2031) & (US$ Million)
Figure 47. U.K. Solid Oral Nutraceutical Excipient Revenue (2020-2031) & (US$ Million)
Figure 48. Italy Solid Oral Nutraceutical Excipient Revenue (2020-2031) & (US$ Million)
Figure 49. Russia Solid Oral Nutraceutical Excipient Revenue (2020-2031) & (US$ Million)
Figure 50. Asia-Pacific Solid Oral Nutraceutical Excipient Sales YoY (2020-2031) & (K Units)
Figure 51. Asia-Pacific Solid Oral Nutraceutical Excipient Revenue YoY (2020-2031) & (US$ Million)
Figure 52. Asia-Pacific Top 8 Manufacturers Solid Oral Nutraceutical Excipient Sales Revenue (US$ Million) in 2024
Figure 53. Asia-Pacific Solid Oral Nutraceutical Excipient Sales Volume (K Units) by Type (2020- 2031)
Figure 54. Asia-Pacific Solid Oral Nutraceutical Excipient Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 55. Asia-Pacific Solid Oral Nutraceutical Excipient Sales Volume (K Units) by Application (2020-2031)
Figure 56. Asia-Pacific Solid Oral Nutraceutical Excipient Sales Revenue (US$ Million) by Application (2020-2031)
Figure 57. Indonesia Solid Oral Nutraceutical Excipient Revenue (2020-2031) & (US$ Million)
Figure 58. Japan Solid Oral Nutraceutical Excipient Revenue (2020-2031) & (US$ Million)
Figure 59. South Korea Solid Oral Nutraceutical Excipient Revenue (2020-2031) & (US$ Million)
Figure 60. China Taiwan Solid Oral Nutraceutical Excipient Revenue (2020-2031) & (US$ Million)
Figure 61. India Solid Oral Nutraceutical Excipient Revenue (2020-2031) & (US$ Million)
Figure 62. Central and South America Solid Oral Nutraceutical Excipient Sales YoY (2020-2031) & (K Units)
Figure 63. Central and South America Solid Oral Nutraceutical Excipient Revenue YoY (2020-2031) & (US$ Million)
Figure 64. Central and South America Top 5 Manufacturers Solid Oral Nutraceutical Excipient Sales Revenue (US$ Million) in 2024
Figure 65. Central and South America Solid Oral Nutraceutical Excipient Sales Volume (K Units) by Type (2021-2031)
Figure 66. Central and South America Solid Oral Nutraceutical Excipient Sales Revenue (US$ Million) by Type (2020-2031)
Figure 67. Central and South America Solid Oral Nutraceutical Excipient Sales Volume (K Units) by Application (2020-2031)
Figure 68. Central and South America Solid Oral Nutraceutical Excipient Sales Revenue (US$ Million) by Application (2020-2031)
Figure 69. Brazil Solid Oral Nutraceutical Excipient Revenue (2020-2025) & (US$ Million)
Figure 70. Argentina Solid Oral Nutraceutical Excipient Revenue (2020-2025) & (US$ Million)
Figure 71. Middle East, and Africa Solid Oral Nutraceutical Excipient Sales YoY (2020-2031) & (K Units)
Figure 72. Middle East and Africa Solid Oral Nutraceutical Excipient Revenue YoY (2020-2031) & (US$ Million)
Figure 73. Middle East and Africa Top 5 Manufacturers Solid Oral Nutraceutical Excipient Sales Revenue (US$ Million) in 2024
Figure 74. Middle East and Africa Solid Oral Nutraceutical Excipient Sales Volume (K Units) by Type (2021-2031)
Figure 75. South America Solid Oral Nutraceutical Excipient Sales Revenue (US$ Million) by Type (2020-2031)
Figure 76. Middle East and Africa Solid Oral Nutraceutical Excipient Sales Volume (K Units) by Application (2020-2031)
Figure 77. Middle East and Africa Solid Oral Nutraceutical Excipient Sales Revenue (US$ Million) by Application (2020-2031)
Figure 78. GCC Countries Solid Oral Nutraceutical Excipient Revenue (2020-2025) & (US$ Million)
Figure 79. Turkey Solid Oral Nutraceutical Excipient Revenue (2020-2025) & (US$ Million)
Figure 80. Egypt Solid Oral Nutraceutical Excipient Revenue (2020-2025) & (US$ Million)
Figure 81. South Africa Solid Oral Nutraceutical Excipient Revenue (2020-2025) & (US$ Million)
Figure 82. Solid Oral Nutraceutical Excipient Industry Chain Mapping
Figure 83. Regional Solid Oral Nutraceutical Excipient Manufacturing Base Distribution (%)
Figure 84. Global Solid Oral Nutraceutical Excipient Production Market Share by Region (2020-2031)
Figure 85. Solid Oral Nutraceutical Excipient Production Process
Figure 86. Regional Solid Oral Nutraceutical Excipient Production Cost Structure
Figure 87. Channels of Distribution (Direct Vs Distribution)
Figure 88. Bottom-up and Top-down Approaches for This Report
Figure 89. Data Triangulation
Figure 90. Key Executives Interviewed
